Dorian Cheff

Dorian Cheff is a Senior Scientist at AstraZeneca, specializing in biochemical assay development. They were previously a PhD student at the Karolinska Institutet, where they developed high-throughput screening pipelines to identify novel inhibitors of human selenoprotein glutathione peroxidases and mentored multiple students. As an NIH-KI Pre-Doctoral Fellow at the National Center for Advancing Translational Sciences, they contributed to research aimed at understanding the role of GPX in disease contexts. Dorian holds a Bachelor of Science in Neuroscience from the University of Michigan and has extensive experience in both basic and translational science.